[go: up one dir, main page]

MX2017000472A - Combinacion de extracto de raiz de valeriana y aceite de lavanda para su utilizacion en el tratamiento de trastornos del sueño. - Google Patents

Combinacion de extracto de raiz de valeriana y aceite de lavanda para su utilizacion en el tratamiento de trastornos del sueño.

Info

Publication number
MX2017000472A
MX2017000472A MX2017000472A MX2017000472A MX2017000472A MX 2017000472 A MX2017000472 A MX 2017000472A MX 2017000472 A MX2017000472 A MX 2017000472A MX 2017000472 A MX2017000472 A MX 2017000472A MX 2017000472 A MX2017000472 A MX 2017000472A
Authority
MX
Mexico
Prior art keywords
combination
root extract
treatment
lavender oil
sleep disorders
Prior art date
Application number
MX2017000472A
Other languages
English (en)
Inventor
Dimpfel Wilfried
Nöldner Michael
Original Assignee
Dr Willmar Schwabe Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe Gmbh & Co Kg filed Critical Dr Willmar Schwabe Gmbh & Co Kg
Publication of MX2017000472A publication Critical patent/MX2017000472A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona a una combinación de extracto de raíz de valeriana y aceite de lavanda para el tratamiento de trastornos del sueño, así como a una combinación de una preparación que comprende extracto de raíz de valeriana y aceite de lavanda.
MX2017000472A 2014-07-14 2015-06-10 Combinacion de extracto de raiz de valeriana y aceite de lavanda para su utilizacion en el tratamiento de trastornos del sueño. MX2017000472A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14176927.3A EP2974733B1 (de) 2014-07-14 2014-07-14 Kombination von Baldrianwurzelextrakt und Lavendelöl zur Verwendung zur Behandlung von Schlafstörungen
PCT/EP2015/062891 WO2016008650A1 (de) 2014-07-14 2015-06-10 Kombination von baldrianwurzelextrakt und lavendelöl zur verwendung zur behandlung von schlafstörungen

Publications (1)

Publication Number Publication Date
MX2017000472A true MX2017000472A (es) 2017-04-27

Family

ID=51167804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000472A MX2017000472A (es) 2014-07-14 2015-06-10 Combinacion de extracto de raiz de valeriana y aceite de lavanda para su utilizacion en el tratamiento de trastornos del sueño.

Country Status (16)

Country Link
US (1) US10357530B2 (es)
EP (1) EP2974733B1 (es)
JP (1) JP6474114B2 (es)
KR (1) KR102231129B1 (es)
CN (1) CN106573029B (es)
AU (1) AU2015291363B2 (es)
CA (1) CA2953190C (es)
ES (1) ES2597784T3 (es)
HU (1) HUE031669T2 (es)
MX (1) MX2017000472A (es)
MY (1) MY177827A (es)
PL (1) PL2974733T3 (es)
PT (1) PT2974733T (es)
RU (1) RU2672876C2 (es)
TW (1) TWI654987B (es)
WO (1) WO2016008650A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7576905B2 (ja) 2016-05-06 2024-11-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー バレリアン組成物及び関連方法
CN108042658A (zh) * 2017-11-17 2018-05-18 贵州苗药生物技术有限公司 一种缬草苗药睡眠精油组合物及其制备方法和应用
JP6961481B2 (ja) * 2017-12-26 2021-11-05 株式会社ファンケル 脳血流改善用組成物
CN111388572A (zh) * 2020-04-13 2020-07-10 北京中医药大学 一种复方精油及其制备方法、制剂和应用
KR20240134719A (ko) * 2022-01-18 2024-09-10 옴니액티브 헬스 테크놀로지스 리미티드 수면 관리용 발레리안 조성물
KR102885894B1 (ko) * 2022-12-30 2025-11-19 농업회사법인우포의아침 주식회사 천연 추출물을 이용한 수면장애 개선 식품 제조방법
CN118600573B (zh) * 2024-04-10 2025-02-07 和也健康科技有限公司 一种薰衣草、缬草改性植物基纤维及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2106873C1 (ru) * 1994-03-16 1998-03-20 Николай Николаевич Бобров-Егоров Бальзамическое биологически активное средство - фитаон-4 и способ его получения
JPH1025246A (ja) 1996-07-11 1998-01-27 Kobayashi Pharmaceut Co Ltd 催眠剤、催眠性飲食物及び催眠性餌料
RU2215536C2 (ru) * 1999-07-15 2003-11-10 Сергей Иванович Гулый Биологически активная пищевая добавка лечебно-профилактического действия, обладающая седативными свойствами, способ ее получения
US6869622B2 (en) 1999-07-21 2005-03-22 Ancile Pharmaceuticals, Inc. Composition for improving sleep quality and efficiency, and methods of preparing and using the composition
DE102004048716A1 (de) * 2004-10-06 2006-04-20 Dr. Willmar Schwabe Gmbh & Co. Kg Verwendung von Lavendelöl zur Prophylaxe und Behandlung von Neurasthenie, Somatisierungsstörungen und von anderen stress-assoziierten Erkrankungen
WO2007095716A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
US20090061029A1 (en) * 2007-08-28 2009-03-05 Kaira Rouda Nighttime water
WO2010065194A2 (en) * 2008-12-03 2010-06-10 Elc Management Llc Compositions and methods for promoting a relaxation state
WO2011098394A2 (de) * 2010-02-09 2011-08-18 Reiner Rittinghausen Zusammmensetzung zur behandlung und prophylaxe von nervösen störungen und schlafstörungen
EP2568954A4 (en) * 2010-05-10 2016-01-27 Segetis Inc FRAGRANCE FORMULATIONS, METHOD FOR THE PRODUCTION THEREOF AND ARTICLES THEREWITH
KR20120122109A (ko) * 2011-04-28 2012-11-07 애경산업(주) 허브 추출물을 함유하는 탈모 방지 및 양모 촉진용 모발 또는 두피 화장료 조성물
US20130004599A1 (en) * 2011-06-30 2013-01-03 Masada Health & Beauty Corporation Formulation for transdermal delivery to promote sleep
KR101296920B1 (ko) * 2013-01-21 2013-08-14 강영숙 숙면을 위한 마사지 오일
CN103142910B (zh) * 2013-03-08 2014-07-09 张风华 安神脐贴
US9375463B2 (en) * 2013-09-10 2016-06-28 Creative Medical Health, Inc. Compositions and methods for improving sleep using a nutraceutical formulation
CN103750535B (zh) * 2014-01-22 2015-12-02 红云红河烟草(集团)有限责任公司 一种加热非燃烧型卷烟烟块的制备方法
WO2015142611A1 (en) * 2014-03-20 2015-09-24 Santé, Llc Pre-operative beverages

Also Published As

Publication number Publication date
CA2953190A1 (en) 2016-01-21
RU2017101445A (ru) 2018-08-14
KR102231129B1 (ko) 2021-03-24
AU2015291363B2 (en) 2020-04-02
WO2016008650A1 (de) 2016-01-21
HUE031669T2 (en) 2017-07-28
PT2974733T (pt) 2016-10-24
JP6474114B2 (ja) 2019-02-27
RU2017101445A3 (es) 2018-08-14
TWI654987B (zh) 2019-04-01
EP2974733B1 (de) 2016-09-07
RU2672876C2 (ru) 2018-11-20
CN106573029B (zh) 2021-05-11
US20170296612A1 (en) 2017-10-19
EP2974733A1 (de) 2016-01-20
JP2017521446A (ja) 2017-08-03
TW201613628A (en) 2016-04-16
ES2597784T3 (es) 2017-01-23
MY177827A (en) 2020-09-23
CN106573029A (zh) 2017-04-19
PL2974733T3 (pl) 2017-09-29
CA2953190C (en) 2022-05-24
AU2015291363A1 (en) 2017-01-12
KR20170029604A (ko) 2017-03-15
US10357530B2 (en) 2019-07-23

Similar Documents

Publication Publication Date Title
GB2542155B (en) Use of cannabidiol in the treatment of mental disorders
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
MX2016017108A (es) Composiciones y metodos para el cuidado personal.
MX2017002271A (es) Composiciones y metodos para el tratamiento de trastornos neurologicos.
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
PH12017500621A1 (en) Triazolopyrazinones as pde1 inhibitors
HUE043531T2 (hu) Kezelési eljárás nemes-, nem nemes- és ritkafémek kivonására
MX2017000472A (es) Combinacion de extracto de raiz de valeriana y aceite de lavanda para su utilizacion en el tratamiento de trastornos del sueño.
MX380252B (es) Crenezumab para usarse en el tratamiento de enfermedad de alzheimer.
CA159367S (en) Fryer
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
EA201691108A1 (ru) Хиназолин-thf-амины в качестве ингибиторов pde1
PH12016501495A1 (en) Hexahydrofuropyrroles as pde1 inhibitors
LT3229790T (lt) Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme
AU362165S (en) Drug delivery device
GB201423272D0 (en) The combination for anti-wrinkle and soothing the skin
MX2016005505A (es) Modulador de la proteina de transferencia de ester de colesterilo (cetp) para usarse en el tratamiento de enfermedades oculares.
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
PH12016502311A1 (en) Omega-3 analogues
PL3157918T3 (pl) Pochodne 2-arylo-4-hydroksy-1,3-tiazolowe użyteczne jako inhibitory TRPM8 w leczeniu nerwobólu, bólu, POChP i astmy
AU355238S (en) Dental appliance
PH12020500472A1 (en) Autotaxin inhibitor compounds
MA39718A (fr) Compositions et méthodes d'utilisation de celles-ci
CA159935S (en) Nasal dilator
ZA201606113B (en) Composition for relieving pain, stress and insomnia

Legal Events

Date Code Title Description
FG Grant or registration